MILAN — Psilocybin leads to a better overall outcome in the treatment of moderate to severe major depressive disorder (MDD) than the selective serotonin reuptake inhibitor (SSRI) escitalopram, results ...
Postpartum maternal mental health and mother-to-infant bonding are well-established as critical factors in a child's psychosocial development. However, few studies have explored the combined impact of ...
Please provide your email address to receive an email when new articles are posted on . Patients showed significant decreases in depression and anxiety scores from baseline to 5-year follow-up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback